The EVAMS – Emerging Voices in Cancer Research is a multidisciplinary international symposium fully committed to amplifying early-career contributions in oncology.
Born as the closing event of a Ministry-funded research project on innovative theranostic strategies targeting ALDH1A3 — a key biomarker of cancer stem-like cells and a promising lever for precision diagnostics and therapy — EVAMS aims to provide a vibrant platform for young researchers at the forefront of cancer science.
Throughout the day, PhD students, postdoctoral fellows, residents, and early-career investigators will take the stage to present their original research through oral communications, flash talks, and poster sessions.
🚫Registration for in person attendance is not anymore possible: we reached the maximum number of attendees allowed!
THANK YOU ALL 🙏!!!
💻Registration for virtual participation is still open.
SCOPE AND HIGHLIGHTS
This international event will bring together emerging talents and leading experts from diverse fields—chemistry, biochemistry, pharmacology, biotechnology, and medicine—to share and discuss cutting-edge discoveries in cancer research.
The symposium will conclude with a special focus session dedicated to Aldehyde Dehydrogenase (ALDH) as an innovative pharmacological target in brain cancer, the central topic of the co-funded research project.
SCIENTIFIC COMMITTEE
Prof Concettina La Motta – University of Pisa
Dr Ilaria D’Agostino – University of Pisa
Prof Silvia Garavaglia – University of Eastern Piedmont
Prof Lorenzo Magrassi – University of Pavia